Atlanta Allergy & Asthma will be CLOSED on the following days during the 2022 Holiday Season:
Thanksgiving Day (11/24), Day After Thanksgiving (11/25), Monday after Christmas (12/26), and Monday After New Year’s (1/2).

Current Trials

All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided. You do not need to be a current patient of Atlanta Allergy & Asthma to participate in a research study.


Participants Needed for Peanut Allergy Study: Epicutaneous Peanut Immunotherapy

Qualifications to be considered for this study:

  • Children ages 4 to 11
  • Physician -diagnosed peanut allergy or children with a well-documented medical history of Ige-mediated reaction(s) after ingestion with peanut. (Children with a history of anaphylaxis, including severe anaphylaxis to peanut will be eligible)
  • Peanut-specific  positive peanut skin prick test and peanut blood test Not currently on immunotherapy for any allergen (including environmental & insect allergy)
  • No monoclonal antibody therapy within 6 months of screening
  • No uncontrolled persistent asthma

To learn more, please contact Martha Coggins at our Stockbridge Research facility.

Phone: 770.996.5354

Email: [email protected]

Participants Needed for Chronic Spontaneous Urticaria (CSU) Study:

Qualifications to be considered for this study:

  • Ages 18 and up
  • CSU duration greater than 6 months
  • CSU inadequately controlled by H1-antihistamines
  • Documentation of hives within 3 months before screening
  • Willing to complete a urticaria patient daily diary for the duration of the study
  • Participants cannot have monoclonal antibody treatment within 4 months of screening

To learn more, please contact Martha Coggins at our Stockbridge Research facility.

Phone: 770.996.5354

Email: [email protected]

Participants Needed for Peanut Allergy Study:

Qualifications to be considered for this study:

  • Ages 6 to 55
  • Documented medical history of allergy to peanuts or peanut containing foods
  • Participants must be able to receive injections (study treatment)
  • No uncontrolled asthma
  • No monoclonal antibody treatment within 6 months of screening

To learn more, please contact Janet Plumley at our Kennestone Research facility.

Phone: 770.592.4210

Email: [email protected]